| Evaluation of Optical Coherence Tomography. (NCT01080898) | Assistance Publique - Hôpitaux de Paris | 2010-04-01 |
| A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration (NCT01089517) | Ophthotech Corporation | 2010-03-01 |
| Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD) (NCT01148511) | Novartis Pharmaceuticals | 2010-02-01 |
| Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD (NCT05678517) | Semmelweis University | 2010-01-01 |
| Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice (NCT00787319) | Pfizer | 2010-01-01 |
| Foresee Home for Monitoring Age Related Macular Degeneration (AMD) (NCT01010997) | Notal Vision Ltd. | 2009-12-01 |
| Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration (NCT01777984) | Rudolf Foundation Clinic | 2009-12-01 |
| INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD (NCT01016873) | Oraya Therapeutics, Inc. | 2009-11-01 |
| Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) (NCT00557791) | OPKO Health, Inc. | 2009-11-01 |
| Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). (NCT00713518) | Quark Pharmaceuticals | 2009-11-01 |
| Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment (NCT01083147) | Notal Vision Ltd. | 2009-10-01 |
| Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration (NCT01048476) | Peking University | 2009-09-01 |
| Age-Related Macular Degeneration (AMD) - Usability Study (NCT00963339) | Notal Vision Ltd. | 2009-09-01 |
| Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) (NCT00931489) | Lawrence S. Morse, MD | 2009-08-01 |
| Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) (NCT01073592) | Notal Vision Ltd. | 2009-08-01 |
| Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal (NCT01298674) | Association for Innovation and Biomedical Research on Light and Image | 2009-08-01 |
| A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD (NCT01013376) | MacuCLEAR, Inc. | 2009-08-01 |
| Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD) (NCT00935883) | Philip J. Rosenfeld, MD, PhD | 2009-07-01 |
| Effect of Lutein-enriched-egg Beverage on Age-Related Macular Degeneration (AMD) (NCT00902408) | Maastricht University Medical Center | 2009-07-01 |
| French Evaluation Group Avastin Versus Lucentis (NCT01170767) | Hospices Civils de Lyon | 2009-06-01 |
| Effect of Saffron Supplementation on Macular Cone-mediated Function in Age-related Macular Degeneration (NCT00951288) | Catholic University of the Sacred Heart | 2009-06-01 |
| Low Vision Depression Prevention Trial for Age Related Macular Degeneration (NCT00769015) | Thomas Jefferson University | 2009-06-01 |
| Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects (NCT00884637) | Notal Vision Ltd. | 2009-06-01 |
| Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization (NCT01350323) | University of Molise | 2009-05-01 |
| Macular Pigment Optical Density in Healthy Subjects (NCT00993330) | Medical University of Vienna | 2009-05-01 |
| Macular Degeneration and Aging Study (NCT02224963) | University of Rochester | 2009-05-01 |
| Geographic Atrophy Treatment Evaluation (NCT00890097) | Alcon Research | 2009-04-01 |
| Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration (NCT01014468) | Instituto de Olhos de Goiania | 2009-03-01 |
| The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration (NCT00857259) | Novartis Pharmaceuticals | 2009-02-01 |
| Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients (NCT00748384) | Notal Vision Ltd. | 2009-02-01 |
| The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration (NCT01330797) | Uludag University | 2009-01-01 |
| Macular Function During Anti-VEGF Treatment (NCT01023971) | Royal Liverpool University Hospital | 2009-01-01 |
| Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (NCT00826371) | Novartis Pharmaceuticals | 2009-01-01 |
| Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)? (NCT00813514) | Medical University of Vienna | 2009-01-01 |
| Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics (NCT00831961) | Vanderbilt University | 2009-01-01 |
| Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration (NCT00805233) | Oregon Health and Science University | 2008-12-01 |
| Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration (NCT00766337) | Santen Inc. | 2008-12-01 |
| Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy (NCT00695318) | Alimera Sciences | 2008-12-01 |
| Subretinal Macugen® for Neovascular Age-Related Macular Degeneration (NCT00788177) | Klinikum Ludwigshafen | 2008-11-01 |
| Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography (NCT00797524) | Association for Innovation and Biomedical Research on Light and Image | 2008-11-01 |
| ERG/EOG Study in AMD Patients Treated With Ranibizumab (NCT00791427) | Retina Center, Minnesota | 2008-11-01 |
| Usability of the PreView PHP for Home Use in Intermediate AMD Patients (NCT00776451) | Notal Vision Ltd. | 2008-11-01 |
| A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy (NCT00809419) | NeoVista | 2008-11-01 |
| Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab (NCT00776763) | Ophthalmological Association Edelweiss | 2008-10-01 |
| A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration (NCT00782093) | Ophthotech Corporation | 2008-10-01 |
| Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy (NCT00791570) | Osaka University | 2008-10-01 |
| Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD (NCT00766649) | National Eye Institute (NEI) | 2008-10-01 |
| Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration (NCT00712491) | Santen Inc. | 2008-09-01 |
| Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration (NCT01174407) | Rudolf Foundation Clinic | 2008-09-01 |
| Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (NCT01217762) | Oraya Therapeutics, Inc. | 2008-07-01 |
| Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration (NCT00710229) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2008-07-01 |
| Age-Related Eye Disease Study (AREDS) Follow-Up (NCT00594672) | National Eye Institute (NEI) | 2008-06-02 |
| Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab (NCT00864838) | University of Sao Paulo | 2008-06-01 |
| Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV) (NCT00692887) | Notal Vision Ltd. | 2008-06-01 |
| Study EvAluating Genotypes While Using Lucentis 2 (NCT01464723) | University of California, San Diego | 2008-05-01 |
| Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF (NCT00607750) | CoMentis | 2008-05-01 |
| Assessment of Macular Edema Using HRT Technique (NCT00627718) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2008-04-01 |
| Genetic Assessment of Early to Late Macular Degeneration Study (NCT01464710) | Henry Ferreyra | 2008-04-01 |
| Usage of the Home Macular Perimeter (HMP) (NCT00596388) | Notal Vision Ltd. | 2008-03-01 |
| Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (NCT00726466) | Vitreous -Retina- Macula Consultants of New York | 2008-03-01 |
| Sensitivity and Specificity of the Home Macular Perimeter (HMP) (NCT00595998) | Notal Vision Ltd. | 2008-01-01 |
| Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) (NCT00603850) | Notal Vision Ltd. | 2008-01-01 |
| The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot (NCT00605423) | Johns Hopkins University | 2008-01-01 |
| Investigation of Macular Pigment Augmentation on Dark Adaptation (NCT00478439) | University of Alabama at Birmingham | 2007-12-01 |
| A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration (NCT00569140) | Ophthotech Corporation | 2007-12-01 |
| The Natural History of Geographic Atrophy Progression (GAP) Study (NCT00599846) | Alcon Research | 2007-12-01 |
| The Zeaxanthin and Visual Function Study (NCT00564902) | Chrysantis, Inc. | 2007-11-01 |
| Sensitivity of the Home Macular Perimeter (HMP) (NCT00604071) | Notal Vision Ltd. | 2007-11-01 |
| HMP (Home Macular Perimeter) -Usability Trial (NCT00592826) | Notal Vision Ltd. | 2007-11-01 |
| Stratus Versus Cirrus OCT in AMD (NCT00568191) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2007-10-01 |
| The Effect of Eggs and Egg Products on Macular Pigment (NCT00527553) | Maastricht University Medical Center | 2007-10-01 |
| Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration (NCT00539734) | Prince of Songkla University | 2007-08-01 |
| The Influence of Lutein Supplements on Age-related Macular Degeneration (NCT01042860) | Maastricht University Medical Center | 2007-08-01 |
| CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography (NCT00500344) | Washington University School of Medicine | 2007-07-01 |
| Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants (NCT00487838) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2007-06-14 |
| The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD) (NCT00485394) | Othera Pharmaceuticals | 2007-06-01 |
| EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) (NCT00470678) | Novartis | 2007-06-01 |
| Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy (NCT01255774) | The New York Eye & Ear Infirmary | 2007-06-01 |
| Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration (NCT00517010) | University of California, Davis | 2007-05-01 |
| Use of Self-management Group to Improve Quality of Life in Patients With Low Vision (NCT03046485) | Massachusetts Eye and Ear Infirmary | 2007-05-01 |
| Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT00473928) | Potentia Pharmaceuticals, Inc. | 2007-05-01 |
| Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD (NCT00455871) | Barnes Retina Institute | 2007-04-01 |
| Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD (NCT00446654) | Progen Pharmaceuticals | 2007-04-01 |
| Lucentis KAV Study (NCT01570608) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2007-03-01 |
| A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. (NCT00463320) | GlaxoSmithKline | 2007-03-01 |
| Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD) (NCT00725686) | Quark Pharmaceuticals | 2007-02-01 |
| Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment (NCT00680498) | Illinois Retina Associates | 2007-02-01 |
| A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging (NCT00556114) | University of California, Irvine | 2007-01-01 |
| Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration (NCT00423189) | David M. Brown, M.D. | 2007-01-01 |
| A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration (NCT00395057) | Allergan | 2007-01-01 |
| Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself (NCT00457678) | Vitreous -Retina- Macula Consultants of New York | 2007-01-01 |
| TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration (NCT00464347) | National Eye Institute (NEI) | 2007-01-01 |
| Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular Degeneration (NCT00879671) | Medical University of Vienna | 2006-11-01 |
| The Avastin vs Visudyne for Neovascular AMD Study (NCT00390026) | St. Erik Eye Hospital | 2006-11-01 |
| Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments (NCT00590694) | Pacific Eye Associates | 2006-10-01 |
| Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration (NCT01032109) | Kumamoto University | 2006-10-01 |
| Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) (NCT00413829) | Insel Gruppe AG, University Hospital Bern | 2006-10-01 |
| Combination Therapy for Age-Related Macular Degeneration. (NCT00376701) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-09-01 |
| Age-Related Eye Disease Study 2 (AREDS2) (NCT00345176) | National Eye Institute (NEI) | 2006-09-01 |
| Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration (NCT00390208) | Bay Area Retina Associates | 2006-08-01 |